Related Experiment Video
Updated: Jul 13, 2026

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
Published on: April 7, 2023
Effects of weight control during the menopausal transition on bone mineral density
Hyun A Park1, Jung S Lee, Lewis H Kuller
1Seoul Paik Hospital, College of Medicine, University of Inje, Seoul 100-032, Korea.
Background:
Studies of weight loss and changes in bone mineral density (BMD) have primarily been short-term trials in obese subjects.
Objective:
We examined the effects of a 5-yr intervention designed to prevent menopausal weight gain or promote modest weight loss on BMD in premenopausal women participating in the Women's Healthy Lifestyle Project.
Design:
We enrolled 373 premenopausal women (age 44-50 yr) and randomly assigned them to either lifestyle intervention (175 women, low-fat dietary modification, weight loss, and physical activity intervention) or control group (198 women). BMD and body weight were measured at baseline, annual follow-up visits (18, 30, 42, and 54 months), and two postintervention follow-ups (66 and 78 months). BMD was measured by dual x-ray absorptiometry.
Results:
Over the 54 months of intervention, women in the intervention group lost 0.4 kg, whereas control women gained 2.6 kg (P = 0.011). The intervention group experienced significantly greater hip bone loss (-0.20%/yr) than the control group (-0.03%/yr). During the postintervention, differences in rates of bone loss disappeared. When considering both menopausal status and use of hormone therapy (HT), the annualized BMD changes were lower in women reporting HT use; nevertheless, among women on HT, those who lost more than 3% body weight experienced greater total hip BMD loss (-0.25%/yr) compared with those who gained weight (-0.02%/yr) (P = 0.025).
Conclusions:
Women randomized to a lifestyle intervention aimed at preventing menopausal weight gain or promoting modest weight loss experienced greater rates of hip bone loss than control women.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling
Menopause
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...